{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:35:48Z","timestamp":1773297348025,"version":"3.50.1"},"reference-count":96,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.vaccine.2014.05.009","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T17:01:26Z","timestamp":1400086886000},"page":"3895-3901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Generation of growth arrested Leishmania amastigotes: A tool to develop live attenuated vaccine candidates against visceral leishmaniasis"],"prefix":"10.1016","volume":"32","author":[{"given":"Angamuthu","family":"Selvapandiyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranadhir","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreenivas","family":"Gannavaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumit","family":"Solanki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poonam","family":"Salotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hira L.","family":"Nakhasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.05.009_bib0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fimmu.2012.00069","article-title":"Vaccines for canine leishmaniasis","volume":"3","author":"Palatnik-de-Sousa","year":"2012","journal-title":"Frontiers Immunol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0010","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3201\/eid1707.102002","article-title":"Aircraft and risk of importing a new vector of visceral leishmaniasis","volume":"17","author":"Costa","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0015","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0020","doi-asserted-by":"crossref","first-page":"150746","DOI":"10.1155\/2013\/150746","article-title":"Systematic review into diagnostics for post-kala-azar dermal leishmaniasis (PKDL)","volume":"2013","author":"Adams","year":"2013","journal-title":"J Trop Med"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0025","first-page":"295","article-title":"Challenges in the diagnosis of post kala-azar dermal leishmaniasis","volume":"123","author":"Salotra","year":"2006","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0030","first-page":"820","article-title":"Leishmaniasis in a heart transplant patient","volume":"11","author":"Golino","year":"1992","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0035","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0035-9203(03)00015-4","article-title":"Detection of Leishmania infantum cryptic infection in asymptomatic blood donors living in an endemic area (Eivissa, Balearic Islands, Spain) by different diagnostic methods","volume":"98","author":"Riera","year":"2004","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0040","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/JCM.37.6.1953-1957.1999","article-title":"Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern France","volume":"37","author":"le Fichoux","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0045","doi-asserted-by":"crossref","first-page":"e1284","DOI":"10.1371\/journal.pntd.0001284","article-title":"Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study","volume":"5","author":"Ostyn","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0050","first-page":"568","article-title":"Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen","volume":"9","author":"Singh","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0055","doi-asserted-by":"crossref","first-page":"e2053","DOI":"10.1371\/journal.pntd.0002053","article-title":"Latent infection with Leishmania donovani in highly endemic villages in Bihar, India","volume":"7","author":"Hasker","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0060","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4269\/ajtmh.2007.76.909","article-title":"The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village","volume":"76","author":"Bern","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0065","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.trstmh.2011.08.005","article-title":"Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes","volume":"105","author":"Das","year":"2011","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0070","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1473-3099(10)70320-0","article-title":"Visceral leishmaniasis: elimination with existing interventions","volume":"11","author":"Matlashewski","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0075","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1590\/S0100-879X2005000700001","article-title":"What about Th1\/Th2 in cutaneous leishmaniasis vaccine discovery","volume":"38","author":"Campos-Neto","year":"2005","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.imlet.2005.01.009","article-title":"T helper (h)1\/Th2 and leishmania: paradox rather than paradigm","volume":"99","author":"Alexander","year":"2005","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0085","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.4049\/jimmunol.0900276","article-title":"Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis","volume":"183","author":"Selvapandiyan","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0090","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.4049\/jimmunol.1202801","article-title":"Live attenuated Leishmania donovani p27 gene knockout parasites are nonpathogenic and elicit long-term protective immunity in BALB\/c mice","volume":"190","author":"Dey","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0095","doi-asserted-by":"crossref","first-page":"e2707","DOI":"10.1371\/journal.pntd.0002707","article-title":"Deletion of ubiquitin fold modifier protein Ufm1 processing peptidase Ufsp in L. donovani abolishes Ufm1 processing and alters pathogenesis","volume":"8","author":"Gannavaram","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0100","doi-asserted-by":"crossref","first-page":"7626","DOI":"10.1074\/jbc.M111.307884","article-title":"Adenine aminohydrolase from Leishmania donovani: unique enzyme in parasite purine metabolism","volume":"287","author":"Boitz","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0105","doi-asserted-by":"crossref","first-page":"12759","DOI":"10.1074\/jbc.M112.346502","article-title":"Genetic dissection of pyrimidine biosynthesis and salvage in Leishmania donovani","volume":"287","author":"Wilson","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0110","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1074\/jbc.M110.138313","article-title":"The oligopeptidase B of Leishmania regulates parasite enolase and immune evasion","volume":"286","author":"Swenerton","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0115","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.exppara.2009.03.014","article-title":"Leishmania donovani lacking the Golgi GDP-Man transporter LPG2 exhibit attenuated virulence in mammalian hosts","volume":"122","author":"Gaur","year":"2009","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/IAI.70.1.62-68.2002","article-title":"Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination","volume":"70","author":"Papadopoulou","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0125","first-page":"345","article-title":"Visceral leishmaniasis \u2013 current therapeutic modalities","volume":"123","author":"Sundar","year":"2006","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0130","doi-asserted-by":"crossref","first-page":"580","DOI":"10.4269\/ajtmh.2009.80.580","article-title":"Relapse of visceral leishmaniasis after miltefosine treatment in a Nepalese patient","volume":"80","author":"Pandey","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0135","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1016\/j.vaccine.2005.02.015","article-title":"Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis","volume":"23","author":"Khamesipour","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0140","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1128\/IAI.68.10.5595-5602.2000","article-title":"Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library","volume":"68","author":"Melby","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0145","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.1365-3024.1999.00244.x","article-title":"Vaccination against Leishmania major in a CBA mouse model of infection: role of adjuvants and mechanism of protection","volume":"21","author":"Rivier","year":"1999","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12026-008-8016-2","article-title":"Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies","volume":"41","author":"Okwor","year":"2008","journal-title":"Immunol Res"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0155","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1462-5822.2008.01146.x","article-title":"Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example","volume":"10","author":"Bogdan","year":"2008","journal-title":"Cellular Microbiol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0160","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","article-title":"Leishmaniasis: current status of vaccine development","volume":"14","author":"Handman","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0165","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1128\/IAI.72.6.3622-3627.2004","article-title":"Identification of a compensatory mutant (lpg2-REV) of Leishmania major able to survive as amastigotes within macrophages without LPG2-dependent glycoconjugates and its significance to virulence and immunization strategies","volume":"72","author":"Spath","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0170","doi-asserted-by":"crossref","first-page":"9408","DOI":"10.1200\/JCO.2005.01.5594","article-title":"Targeting the cell cycle: a new approach to cancer therapy","volume":"23","author":"Schwartz","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0175","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1365-2958.2010.07479.x","article-title":"The cell cycle of Leishmania: morphogenetic events and their implications for parasite biology","volume":"79","author":"Wheeler","year":"2011","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0180","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1128\/EC.05118-11","article-title":"Morphological events during the cell cycle of Leishmania major","volume":"10","author":"Ambit","year":"2011","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0185","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2174\/1566524043360285","article-title":"New insights into the developmental biology and transmission mechanisms of Leishmania","volume":"4","author":"Bates","year":"2004","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0190","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpara.2003.10.011","article-title":"Generation of Leishmania donovani axenic amastigotes: their growth and biological characteristics","volume":"34","author":"Debrabant","year":"2004","journal-title":"Int J Parasitol"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2014.05.009_bib0195","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1017\/S0031182000074102","article-title":"Axenic cultivation and characterization of Leishmania mexicana amastigote-like forms","volume":"105","author":"Bates","year":"1992","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0200","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0020-7519(03)00142-5","article-title":"Two separate growth phases during the development of Leishmania in sand flies: implications for understanding the life cycle","volume":"33","author":"Gossage","year":"2003","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0205","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1126\/science.1159194","article-title":"In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies","volume":"321","author":"Peters","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0210","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host-pathogen interface","volume":"9","author":"Kaye","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0215","first-page":"455","article-title":"Genetically modified live attenuated parasites as vaccines for leishmaniasis","volume":"123","author":"Selvapandiyan","year":"2006","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0220","doi-asserted-by":"crossref","first-page":"631460","DOI":"10.1155\/2012\/631460","article-title":"Immunity to visceral leishmaniasis using genetically defined live-attenuated parasites","volume":"2012","author":"Selvapandiyan","year":"2012","journal-title":"J Trop Med"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0225","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1006\/expr.2001.4677","article-title":"Leishmania mexicana: identification of genes that are preferentially expressed in amastigotes","volume":"100","author":"Bellatin","year":"2002","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0230","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1128\/MCB.14.5.2975","article-title":"Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene","volume":"14","author":"Charest","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0235","first-page":"289","article-title":"Indirect prenatal molecular diagnostic of haemophilia A and B","volume":"49","author":"Morales-Machin","year":"2008","journal-title":"Invest Clin"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0240","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molbiopara.2004.02.009","article-title":"Proteomic analysis of Leishmania mexicana differentiation","volume":"136","author":"Nugent","year":"2004","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0245","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/1615-9861(200208)2:8<1007::AID-PROT1007>3.0.CO;2-G","article-title":"A proteomic approach to identify developmentally. regulated proteins in Leishmania infantum","volume":"2","author":"Fakhry","year":"2002","journal-title":"Proteomics"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0250","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1002\/pmic.200500853","article-title":"A combined proteomic and transcriptomic approach to the study of stage differentiation in Leishmania infantum","volume":"6","author":"McNicoll","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0255","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/pmic.200700697","article-title":"Phosphoproteomic analysis of Leishmania donovani pro- and amastigote stages","volume":"8","author":"Morales","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0260","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/pmic.200300462","article-title":"Developmentally induced changes of the proteome in the protozoan parasite Leishmania donovani","volume":"3","author":"Bente","year":"2003","journal-title":"Proteomics"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0265","doi-asserted-by":"crossref","first-page":"11384","DOI":"10.1074\/jbc.M512307200","article-title":"Endosome sorting and autophagy are essential for differentiation and virulence of Leishmania major","volume":"281","author":"Besteiro","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0270","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1073\/pnas.0509196103","article-title":"Virulence of Leishmania major in macrophages and mice requires the gluconeogenic enzyme fructose-1,6-bisphosphatase","volume":"103","author":"Naderer","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0275","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1462-5822.2011.01593.x","article-title":"Quantitative proteome profiling informs on phenotypic traits that adapt Leishmania donovani for axenic and intracellular proliferation","volume":"13","author":"Pescher","year":"2011","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0280","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0014-4894(91)90112-A","article-title":"Leishmania donovani: use of two different, commercially available, chemically defined media for the continuous in vitro cultivation of promastigotes","volume":"73","author":"McCarthy-Burke","year":"1991","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0285","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0166-6851(93)90057-5","article-title":"Cloning and characterization of differentially expressed genes from in vitro-grown \u2018amastigotes\u2019 of Leishmania donovani","volume":"58","author":"Joshi","year":"1993","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0290","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s004360100464","article-title":"Early response gene expression during differentiation of cultured Leishmania donovani","volume":"87","author":"Duncan","year":"2001","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0295","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4269\/ajtmh.1998.59.421","article-title":"Transformation, development, and transmission of axenically cultured amastigotes of Leishmania mexicana in vitro and in Lutzomyia longipalpis","volume":"59","author":"Ismaeel","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0300","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/1874421400903010014","article-title":"Biomarkers of attenuation in the Leishmania donovani centrin gene deleted cell line - requirements for safety in a live vaccine candidate","volume":"3","author":"Duncan","year":"2009","journal-title":"Open Parasitol J"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0305","doi-asserted-by":"crossref","first-page":"25703","DOI":"10.1074\/jbc.M402794200","article-title":"Centrin gene disruption impairs stage-specific basal body duplication and cell cycle progression in Leishmania","volume":"279","author":"Selvapandiyan","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0310","doi-asserted-by":"crossref","first-page":"7170","DOI":"10.1073\/pnas.88.16.7170","article-title":"Double targeted gene replacement for creating null mutants","volume":"88","author":"Cruz","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0315","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0166-6851(00)00210-3","article-title":"Blasticidin resistance: a new independent marker for stable transfection of Leishmania","volume":"108","author":"Goyard","year":"2000","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0320","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0378-1119(95)00042-5","article-title":"The gene encoding streptothricin acetyltransferase (sat) as a selectable marker for Leishmania expression vectors","volume":"156","author":"Joshi","year":"1995","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0325","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0166-6851(93)90175-W","article-title":"Two more independent selectable markers for stable transfection of Leishmania","volume":"62","author":"Freedman","year":"1993","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0330","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1200\/JCO.2005.05.5335","article-title":"Phase II study of belagenpumatucel-l, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer","volume":"24","author":"Nemunaitis","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0335","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/nm1297-1354","article-title":"Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells","volume":"3","author":"Ram","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0340","doi-asserted-by":"crossref","first-page":"10267","DOI":"10.1073\/pnas.92.22.10267","article-title":"Development of a safe live Leishmania vaccine line by gene replacement","volume":"92","author":"Titus","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0345","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1590\/S0074-02762002000700019","article-title":"Study of the safety, immunogenicity and efficacy of attenuated and killed Leishmania (Leishmania) major vaccines in a rhesus monkey (Macaca mulatta) model of the human disease","volume":"97","author":"Amaral","year":"2002","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0350","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1126\/science.1087499","article-title":"Persistence without pathology in phosphoglycan-deficient Leishmania major","volume":"301","author":"Spath","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0355","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.4049\/jimmunol.172.6.3793","article-title":"Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response","volume":"172","author":"Uzonna","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0360","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1002\/eji.200838423","article-title":"Decreased IL-10 and IL-13 production and increased CD44hi T cell recruitment contribute to Leishmania major immunity induced by non-persistent parasites","volume":"38","author":"Kedzierski","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0365","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.4049\/jimmunol.161.12.6794","article-title":"Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response","volume":"161","author":"Alexander","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0370","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1016\/j.vaccine.2005.05.045","article-title":"Pathogenicity and protective immunogenicity of cysteine proteinase-deficient mutants of Leishmania mexicana in non-murine models","volume":"24","author":"Saravia","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0375","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1046\/j.1365-2958.2001.02286.x","article-title":"Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection","volume":"39","author":"Zhang","year":"2001","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0380","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.4049\/jimmunol.179.5.3161","article-title":"SIR2-deficient Leishmania infantum induces a defined IFN-gamma\/IL-10 pattern that correlates with protection","volume":"179","author":"Silvestre","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0385","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2958.2010.07214.x","article-title":"Characterization of a Leishmania stage-specific mitochondrial membrane protein that enhances the activity of cytochrome c oxidase and its role in virulence","volume":"77","author":"Dey","year":"2010","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0390","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2958.2012.08183.x","article-title":"Deletion of mitochondrial associated ubiquitin fold modifier protein Ufm1 in Leishmania donovani results in loss of beta-oxidation of fatty acids and blocks cell division in the amastigote stage","volume":"86","author":"Gannavaram","year":"2012","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0395","doi-asserted-by":"crossref","first-page":"43253","DOI":"10.1074\/jbc.M106806200","article-title":"Expression of a mutant form of Leishmania donovani centrin reduces the growth of the parasite","volume":"276","author":"Selvapandiyan","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0400","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1091\/mbc.E07-01-0022","article-title":"Centrin1 iss required for organelle segregation and cytokinesis in Trypanosoma brucei","volume":"18","author":"Selvapandiyan","year":"2007","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0405","doi-asserted-by":"crossref","first-page":"31871","DOI":"10.1074\/jbc.M800028200","article-title":"Centrins, cell cycle regulation proteins in human malaria parasite Plasmodium falciparum","volume":"283","author":"Mahajan","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0410","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.vaccine.2013.01.048","article-title":"Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs","volume":"31","author":"Fiuza","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0415","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1128\/CVI.00290-09","article-title":"Vaccines: the fourth century","volume":"16","author":"Plotkin","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0420","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0264-410X(96)00252-6","article-title":"Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization","volume":"15","author":"Sizemore","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0425","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1586\/14760584.2013.825454","article-title":"Salmonella as a vaccine delivery vehicle","volume":"12","author":"Roland","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0430","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/10717544.2013.801534","article-title":"A non-pathogenic live vector as an efficient delivery system in vaccine design for the prevention of HPV16 E7-overexpressing cancers","volume":"20","author":"Hosseinzadeh","year":"2013","journal-title":"Drug Deliv"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0435","doi-asserted-by":"crossref","first-page":"e2174","DOI":"10.1371\/journal.pntd.0002174","article-title":"Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis","volume":"7","author":"Saljoughian","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0440","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.4049\/jimmunol.167.9.5226","article-title":"Sandfly maxadilan exacerbates infection with Leishmania major and vaccinating against it protects against L. major infection","volume":"167","author":"Morris","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0445","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1084\/jem.194.3.331","article-title":"Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein","volume":"194","author":"Valenzuela","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0450","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1038\/jid.2012.205","article-title":"Immunity to sand fly salivary protein LJM11 modulates host response to vector-transmitted leishmania conferring ulcer-free protection","volume":"132","author":"Gomes","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0455","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1073\/pnas.0712153105","article-title":"Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model","volume":"105","author":"Gomes","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0460","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ng2053","article-title":"Comparative genomic analysis of three Leishmania species that cause diverse human disease","volume":"39","author":"Peacock","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0465","doi-asserted-by":"crossref","first-page":"892817","DOI":"10.1155\/2012\/892817","article-title":"Development of vaccines against visceral leishmaniasis","volume":"2012","author":"Evans","year":"2012","journal-title":"J Trop Med"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0470","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1093\/nar\/gkt071","article-title":"A comprehensive approach to zinc-finger recombinase customization enables genomic targeting in human cells","volume":"41","author":"Gaj","year":"2013","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0475","doi-asserted-by":"crossref","first-page":"31120","DOI":"10.1074\/jbc.M110.114462","article-title":"Leishmania subtilisin is a maturase for the trypanothione reductase system and contributes to disease pathology","volume":"285","author":"Swenerton","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2014.05.009_bib0480","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1756-3305-4-150","article-title":"Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation","volume":"4","author":"Carrion","year":"2011","journal-title":"Parasites Vectors"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14006653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14006653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T03:57:48Z","timestamp":1689220668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14006653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":96,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0264410X14006653"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of growth arrested Leishmania amastigotes: A tool to develop live attenuated vaccine candidates against visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}